FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells

FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells

Patients with autoimmune lymphoproliferative syndrome (ALPS) and lymphoproliferation (LPR) mice are deficient in Fas, and accumulate large numbers of αβ-TCR+, CD4−, CD8− double negative (DN) T cells. The function of these DN T cells remains largely unknown. The common γ subunit of the activating Fc...

Полное описание

Библиографические подробности
Главные авторы:	Juvet, S, Thomson, C, Kim, E, Han, M, Zhang, L
Формат:	Journal article
Язык:	English
Опубликовано:	Public Library of Science 2013

Схожие документы

FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
по: Stephen C Juvet, и др.
Опубликовано: (2013-01-01)

FcRγ promotes T cell apoptosis in Fas-deficient mice.
по: Juvet, S, и др.
Опубликовано: (2013)

The Diverse Functions of the Ubiquitous Fcγ Receptors and Their Unique Constituent, FcRγ Subunit
по: Thamer A. Hamdan, и др.
Опубликовано: (2020-02-01)

Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.
по: Juvet, S, и др.
Опубликовано: (2012)

Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.
по: Stephen C Juvet, и др.
Опубликовано: (2012-01-01)

A tail of two ITAMs: GPVI/FcRγ and FcγRIIa's role in platelet activation and thrombus stability
по: Keith B. Neeves
Опубликовано: (2021-07-01)

HA antibody mediated FcγRIIIa activity is both dependent on FcR engagement and interactions between HA and sialic acids
по: Freek Cox
Опубликовано: (2016-09-01)

Disulfide-linked dimerization of the FcRγ chain is required for positive and negative regulation of mast cell activation via FcεRI
по: Satoshi Nunomura, и др.
Опубликовано: (2017-09-01)

FcRγIIA attenuates pathology of cutaneous leishmaniasis and modulates ITAMa/i balance
по: Ikram Hammi, и др.
Опубликовано: (2024-12-01)

Harnessing the specialised effector function of FcRγ− NK cells to control HIV-1 infection
по: R. Anderko, и др.
Опубликовано: (2019-12-01)

Blocking of FcR suppresses the intestinal invasion of scrapie agents.
по: Ryuta Uraki, и др.
Опубликовано: (2011-01-01)

FcRγ Gene Editing Reprograms Conventional NK Cells to Display Key Features of Adaptive Human NK Cells
по: Weiru Liu, и др.
Опубликовано: (2020-11-01)

Insulin-regulated aminopeptidase contributes to setting the intensity of FcR-mediated inflammation
по: Manuela Bratti, и др.
Опубликовано: (2022-10-01)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
по: Carolyn M. Boudreau, и др.
Опубликовано: (2019-03-01)

Mixed IgG Fc immune complexes exhibit blended binding profiles and refine FcR affinity estimates
по: Zhixin Cyrillus Tan, и др.
Опубликовано: (2023-07-01)

Loss of DAP12 and FcRγ drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCs.
по: Grzegorz B Gmyrek, и др.
Опубликовано: (2013-01-01)

α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis.
по: Robin J Marjoram, и др.
Опубликовано: (2014-01-01)

Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques
по: Marina Tuyishime, и др.
Опубликовано: (2023-12-01)

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms
по: Robert W. Cross, и др.
Опубликовано: (2023-11-01)

Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults
по: Olivier Lambotte, и др.
Опубликовано: (2013-03-01)

Activating FcγR function depends on endosomal-signaling platforms
по: Samira Benadda, и др.
Опубликовано: (2023-07-01)

Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.
по: Juvet, S, и др.
Опубликовано: (2012)

Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome
по: Stefano Vavassori, и др.
Опубликовано: (2017-06-01)

Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation
по: Yi Xie, и др.
Опубликовано: (2017-02-01)

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
по: Kamel Laribi, и др.
Опубликовано: (2022-06-01)

Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells
по: Jun Shimizu, и др.
Опубликовано: (2022-09-01)

Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome
по: Lenardo Michael J, и др.
Опубликовано: (2007-11-01)

Mutations in the Fas gene found in Spanish ALPS (autoimmune lymphoproliferative syndrome) patients
по: Orta M, и др.
Опубликовано: (2010-11-01)

Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7
по: Humphris, G, и др.
Опубликовано: (2018)

Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7
по: G. M. Humphris, и др.
Опубликовано: (2018-02-01)

Comparison of efficacy and toxicity of FC and FCR regimens in primary B-cell chronic lymphocytic leukemia: a retrospective study
по: Ye. А. Stadnik, и др.
Опубликовано: (2022-11-01)

Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications
по: Laura Batlle-Masó, и др.
Опубликовано: (2022-11-01)

Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells
по: Jun Shimizu, и др.
Опубликовано: (2023-01-01)

CD8α is expressed by human monocytes and enhances FcγR-dependent responses
по: Ng Marcus CY, и др.
Опубликовано: (2007-08-01)

Fc-Linked IgG N-Glycosylation in FcγR Knock-Out Mice
по: Olga O. Zaytseva, и др.
Опубликовано: (2020-03-01)

Case report: Effectiveness of sirolimus in a de novo FAS mutation leading to autoimmune lymphoproliferative syndrome-FAS and elevated DNT/Treg ratio
по: Hao Gu, и др.
Опубликовано: (2022-07-01)

Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder
по: Heiner Zimmermann, и др.
Опубликовано: (2014-01-01)

Transmembrane domain dependent inhibitory function of FcγRIIB
по: Junyi Wang, и др.
Опубликовано: (2018-03-01)

Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease
по: Schafiq Nabhani, и др.
Опубликовано: (2015-09-01)

Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signalling.
по: Emmanuel C Patin, и др.
Опубликовано: (2017-01-01)